These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15789179)

  • 21. Patient self-management of oral anticoagulation.
    Fancher TL; White RH
    Curr Hematol Rep; 2004 Sep; 3(5):368-74. PubMed ID: 15341705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point of care monitors for oral anticoagulant therapy.
    Nutescu EA
    Semin Thromb Hemost; 2004 Dec; 30(6):697-702. PubMed ID: 15630676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Better AVK treatment with self monitoring. Dosage can be regulated in time].
    Stigendal L; André U; Christenson B
    Lakartidningen; 1999 May; 96(20):2482, 2485-7. PubMed ID: 10380494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision and accuracy of point-of-care testing coagulometers used for self-testing and self-management of oral anticoagulation therapy.
    Christensen TD; Larsen TB
    J Thromb Haemost; 2012 Feb; 10(2):251-60. PubMed ID: 22118602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study.
    Gardiner C; Williams K; Mackie IJ; Machin SJ; Cohen H
    Clin Lab Haematol; 2006 Apr; 28(2):122-5. PubMed ID: 16630217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Oral anticoagulant treatment].
    Melis Tormos E
    Rev Enferm; 2009 May; 32(5):48-54. PubMed ID: 19552155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial.
    Siebenhofer A; Rakovac I; Kleespies C; Piso B; Didjurgeit U
    Thromb Haemost; 2007 Mar; 97(3):408-16. PubMed ID: 17334508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge base of clinicians regarding oral anticoagulant therapy in a teaching institution--a questionnaire survey.
    Kakkar N; Kaur R
    J Assoc Physicians India; 2004 Nov; 52():868-72. PubMed ID: 15906836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of the performance verification of the CoaguChek XS system.
    Plesch W; Wolf T; Breitenbeck N; Dikkeschei LD; Cervero A; Perez PL; van den Besselaar AM
    Thromb Res; 2008; 123(2):381-9. PubMed ID: 18585761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management.
    Braun S; Watzke H; Hasenkam JM; Schwab M; Wolf T; Dovifat C; Völler H
    Thromb Haemost; 2007 Feb; 97(2):310-4. PubMed ID: 17264962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the international normalized ratio (INR) in a new point-of-care system designed for home monitoring of oral anticoagulation therapy.
    Plesch W; van den Besselaar AM
    Int J Lab Hematol; 2009 Feb; 31(1):20-5. PubMed ID: 19143869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point-of-care antithrombotic monitoring in children.
    Newall F; Bauman M
    Thromb Res; 2006; 118(1):113-21. PubMed ID: 16709480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Update of INR-selfmonitoring].
    Völler H; Braun S
    Hamostaseologie; 2008 Oct; 28(4):231-3. PubMed ID: 18836650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
    McGlasson DL; Romick BG; Rubal BJ
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality evaluation of the management of oral anticoagulation therapy (OAT): the awareness of treating physicians and the education of patients needs to be improved.
    Gras-Champel V; Voyer A; Guillaume N; Lematte C; Roussel B; Machu-Prestaux C; Andréjak M; Lefrère JJ
    Am J Ther; 2006; 13(3):223-8. PubMed ID: 16772764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual patient meta-analysis of self-monitoring of an oral anticoagulation protocol.
    Perera R; Heneghan C; Fitzmaurice D;
    J Heart Valve Dis; 2008 Mar; 17(2):233-8. PubMed ID: 18512497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
    Phillips KW; Ansell J
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.